Arrowhead Research Corporation Prices At-Market Private Offering for $60 Million Net Proceeds
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it has priced a private offering with net proceeds expected to be $60 million. The offering was priced at $5.86 per share of common stock.
Help employers find you! Check out all the jobs and post your resume.